C
Caroline Der Nigoghossian
Researcher at NewYork–Presbyterian Hospital
Publications - 15
Citations - 3989
Caroline Der Nigoghossian is an academic researcher from NewYork–Presbyterian Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 8 publications receiving 2850 citations. Previous affiliations of Caroline Der Nigoghossian include Columbia University Medical Center.
Papers
More filters
Journal ArticleDOI
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Behnood Bikdeli,Mahesh V. Madhavan,David Jiménez,Taylor Chuich,Isaac Dreyfus,Elissa Driggin,Caroline Der Nigoghossian,Walter Ageno,Mohammad Madjid,Yutao Guo,Liang V. Tang,Yu Hu,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Joseph A. Caprini,Alfonso Tafur,John R. Burton,Dominic P. Francese,Elizabeth Y. Wang,Anna Falanga,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,John W. Eikelboom,Ido Weinberg,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,P. Gabriel Steg,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +50 more
TL;DR: The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
Journal ArticleDOI
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic.
Elissa Driggin,Mahesh V. Madhavan,Behnood Bikdeli,Taylor Chuich,Justin Laracy,Giuseppe Biondi-Zoccai,Tyler S. Brown,Caroline Der Nigoghossian,David A. Zidar,Jennifer Haythe,Daniel Brodie,Joshua A. Beckman,Ajay J. Kirtane,Gregg W. Stone,Harlan M. Krumholz,Sahil A. Parikh +15 more
TL;DR: The peer-reviewed and preprint literature pertaining to cardiovascular considerations related to COVID-19 are reviewed to highlight gaps in knowledge that require further study pertinent to patients, health care workers, and health systems.
Journal ArticleDOI
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Behnood Bikdeli,Behnood Bikdeli,Mahesh V. Madhavan,Aakriti Gupta,Aakriti Gupta,David Jiménez,John R. Burton,Caroline Der Nigoghossian,Taylor Chuich,Shayan Nabavi Nouri,Isaac Dreyfus,Elissa Driggin,Sanjum S. Sethi,Kartik Sehgal,Kartik Sehgal,Saurav Chatterjee,Walter Ageno,Mohammad Madjid,Yutao Guo,Yutao Guo,Liang V. Tang,Yu Hu,Laurent Bertoletti,Jay Giri,Jay Giri,Jay Giri,Mary Cushman,Isabelle Quéré,Evangelos Dimakakos,C. Michael Gibson,C. Michael Gibson,Giuseppe Lippi,Emmanuel J. Favaloro,Jawed Fareed,Alfonso Tafur,Alfonso Tafur,Dominic P. Francese,Jaya Batra,Anna Falanga,Kevin J. Clerkin,Nir Uriel,Ajay J. Kirtane,Claire McLintock,Beverley J. Hunt,Alex C. Spyropoulos,Geoffrey D. Barnes,John W. Eikelboom,Ido Weinberg,Sam Schulman,Sam Schulman,Marc Carrier,Gregory Piazza,Gregory Piazza,Joshua A. Beckman,Martin B. Leon,Gregg W. Stone,Stephan Rosenkranz,Samuel Z. Goldhaber,Samuel Z. Goldhaber,Sahil A. Parikh,Manuel Monreal,Harlan M. Krumholz,Stavros Konstantinides,Jeffrey I. Weitz,Gregory Y.H. Lip,Gregory Y.H. Lip +65 more
TL;DR: Novel dosing approaches are described for commonly used antithrombotic agents (especially heparin-based regimens) and the potential use of less widely used antithsombotic drugs in the absence of confirmed thrombosis.
Journal ArticleDOI
Effect of Extracorporeal Membrane Oxygenation Use on Sedative Requirements in Patients with Severe Acute Respiratory Distress Syndrome.
Caroline Der Nigoghossian,Amy L. Dzierba,Joshua Etheridge,Russel J. Roberts,Justin Muir,Daniel Brodie,Greg Schumaker,Matthew Bacchetta,Robin Ruthazer,John W. Devlin,John W. Devlin +10 more
TL;DR: To compare sedative dose requirements during the 6‐hour period when they are greatest in patients with severe acute respiratory distress syndrome, as well as the time from severe ARDS onset to reach this maximum sedation exposure, between patients who were managed either with or without extracorporeal membrane oxygenation (ECMO).
Journal ArticleDOI
Prolonged Unconsciousness is Common in COVID‐19 and Associated with Hypoxemia
Greer Waldrop,Seyed A. Safavynia,Megan E Barra,Sachin Agarwal,David A. Berlin,Amelia K. Boehme,D. Brodie,Kevin Doyle,Joseph J. Fins,Wolfgang Ganglberger,Katherine Hoffman,Aaron M. Mittel,David Roh,Shibani S. Mukerji,Caroline Der Nigoghossian,Soo-Jin Park,Edward J. Schenck,John Salazar-Schicchi,Qi-Feng Shen,Evan Sholle,Angela Velazquez,Maria C Walline,M. Brandon Westover,Emery N. Brown,Jonathan D. Victor,Brian L. Edlow,Nicholas D. Schiff,Jan Claassen +27 more
TL;DR: The purpose of this study was to estimate the time to recovery of command‐following and associations between hypoxemia with time to recover of command-following.